Blood-brain barrier dysfunction in cerebral amyloid angiopathy is associated with disseminated cortical superficial siderosis
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Background
Blood–brain barrier (BBB) dysfunction is increasingly recognized as a feature of cerebral amyloid angiopathy (CAA) and has been linked to hemorrhagic imaging manifestations such as cortical superficial siderosis. However, it remains unclear whether neurovascular barrier dysfunction can be captured by routinely available fluid biomarkers and whether such markers identify clinically relevant hemorrhage-prone CAA phenotypes. The CSF/serum albumin quotient (QAlb) is an established marker of neurovascular barrier dysfunction. We investigated Q Alb levels in CAA and their association with imaging markers of disease severity.
Methods
We included 225 participants (115 with CAA, 72 with Alzheimer’s disease [AD], 38 healthy controls) with CSF biomarkers and standardized MRI evaluation. Pathologic Q Alb levels were identified via the age-corrected Reiber-formula. Group differences and determinants of pathological Q Alb were assessed using uni- and multivariable regression analyses. The diagnostic relevance was assessed by receiver operating characteristic analysis.
Results
Q Alb levels were higher in CAA than in controls (ratio of means [RoM] 1.43, 95% CI 1.28–1.58) and patients with AD (RoM 1.22, 95% CI 1.10–1.35; both p<0.001). Pathological Q Alb was independently associated with CAA compared with controls (OR 12.16, 95% CI 2.56–57.86) and AD (OR 2.14, 95% CI 1.07–4.28). Despite these associations, Q Alb showed only moderate discrimination between CAA and controls (AUC 0.75, 95% CI 0.67–0.82) and low discrimination between CAA and AD (AUC 0.63, 95% CI 0.55–0.71). Within the CAA cohort, pathological Q Alb was independently associated with disseminated cortical superficial siderosis (OR 3.92, 95% CI 1.31–11.72; p=0.014), a marker of advanced hemorrhage-prone disease.
Conclusion
QAlb is elevated in patients with CAA and is associated with disseminated cortical superficial siderosis, the strongest predictor of future intracerebral hemorrhage. These findings support an association between neurovascular barrier dysfunction and the hemorrhage-prone phenotype of CAA.
